Viridian Therapeutics Inc - ESG Rating & Company Profile powered by AI
This analysis of Viridian Therapeutics Inc leverages data points from across the web and also from available disclosures by Viridian Therapeutics Inc. Alternative corporations in the rating industry group for Viridian Therapeutics Inc are shown below. The SDG score for Viridian Therapeutics Inc represents the company's reporting of the United Nations SDGs.
Viridian Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.7, social score of 3.2 and governance score of 4.0.
3.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1234 | Quanterix Corp | 3.4 | Medium |
| 1234 | X4 Pharmaceuticals Inc | 3.4 | Medium |
| 1253 | Viridian Therapeutics Inc | 3.3 | Medium |
| 1253 | Calithera Biosciences Inc | 3.3 | Medium |
| 1253 | Cara Therapeutics Inc | 3.3 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Viridian Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Viridian Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Viridian Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Viridian Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Viridian Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Viridian Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Viridian Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Viridian Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Viridian Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Viridian Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Viridian Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Viridian Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Viridian Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Viridian Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Viridian Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Viridian Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Viridian Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Viridian Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was founded in 2006 and is headquartered in Waltham, Massachusetts.